Connecta Therapeutics, a Barcelona, Spain-based biotech company providing neuroplasticity modulators, raised €3.1M in funding. The round was led by Clave Capital through its Innvierte Science Tech Clave Innohealth, F.C.R. fund, with participation from Inveready, CDTI Innvierte, and Prous Institute for Biomedical Research....See more